All Pharma News
Mustang Bio Announces Pricing of $4 Million Public Offering

Mustang Bio Announces Pricing of $4 Million Public Offering
GLOBENEWSWIRE
29 Apr 2024
Share Share
Mustang Bio to lay off workers; MaaT`s new data for microbiome therapy

Mustang Bio to lay off workers; MaaT`s new data for microbiome therapy
ENDPTS
15 Apr 2024
Share Share
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform
GLOBENEWSWIRE
28 Mar 2024
Share Share
CAR-T for brain cancer extends survival in phase 1 trial

CAR-T for brain cancer extends survival in phase 1 trial
Helen Floersh FIERCE BIOTECH
12 Mar 2024
Share Share
Mustang Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mustang Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
GLOBENEWSWIRE
11 Mar 2024
Share Share
Mustang Bio Announces Publication of Data from Phase 1 Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

Mustang Bio Announces Publication of Data from Phase 1 Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
GLOBENEWSWIRE
07 Mar 2024
Share Share
Mustang Bio to Participate in B. Riley Securities 4th Annual Oncology Conference

Mustang Bio to Participate in B. Riley Securities 4th Annual Oncology Conference
GLOBENEWSWIRE
11 Jan 2024
Share Share
Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106
GLOBENEWSWIRE
11 Dec 2023
Share Share
Mustang Bio Reports Third Quarter 2023 Financial Results

Mustang Bio Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
14 Nov 2023
Share Share
Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation

Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation
GLOBENEWSWIRE
02 Nov 2023
Share Share